It has been demonstrated that the chemotherapeutic drugs Daunorubicin and Camptothecin activate the promoter via certain transcription factors, hence stimulating N-SMase transcription in MCF-7 breast cancer cells and K562 leukemia cells. This evidence concerns the gene SMPD2 and breast cancer.